Selenium-driven enhancement of synergistic cancer chemo-/radiotherapy by targeting nanotherapeutics (vol 9, pg 4691, 2021)

被引：0

|

作者：

Liu, Xinxin ^{[1
,2
,3
]}

Yuan, Zhongwen ^{[1
,2
,3
]}

Tang, Zheng ^{[1
,2
,3
]}

Chen, Qi ^{[1
,2
,3
]}

Huang, Jiarun ^{[1
,2
,3
]}

He, Lizhen ^{[1
,2
,3
,4
]}

Chen, Tianfeng ^{[1
,2
,3
,4
]}

机构：

[1] Jinan Univ, Dept Neurol, Guangzhou 510632, Peoples R China

[2] Jinan Univ, Affiliated Hosp 1, Stroke Ctr, Guangzhou 510632, Peoples R China

[3] Jinan Univ, Dept Chem, Guangzhou 510632, Peoples R China

[4] Guangzhou Key Lab Mol & Funct Imaging Clin Transla, Guangzhou 510632, Peoples R China

来源：

BIOMATERIALS SCIENCE | 2022年 / 11卷 / 01期

关键词：

D O I：

10.1039/d2bm90091b

中图分类号：

TB3 [工程材料学]; R318.08 [生物材料学];

学科分类号：

0805 ; 080501 ; 080502 ;

摘要：

引用

收藏

页码：339 / 340

页数：2

相关论文

共 4 条

[1] Selenium-driven enhancement of synergistic cancer chemo-/radiotherapy by targeting nanotherapeutics
Liu, Xinxin
Yuan, Zhongwen
Tang, Zheng
Chen, Qi
Huang, Jiarun
He, Lizhen
Chen, Tianfeng
BIOMATERIALS SCIENCE, 2021, 9 (13) : 4691 - 4700
[2] Concomitant delivery of paclitaxel and NuBCP-9 peptide for synergistic enhancement of cancer therapy (vol 14 , pg 1301, 2018)
Gupta, Dikshi
Kumar, Manoj
Tyagi, Priyanka
Kapoor, Sumeet
Tyagi, Amit
Barman, Tarani Kanta
Kharbanda, Surender
Kufe, Donald
Singh, Harpal
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2018, 14 (07) : 2129 - 2129
[3] RETRACTION: MiR-148a agomir based targeting of c-Met and Her-3 is able to attenuate EGFR-T790M mutation driven gefitinib and erlotinib resistance in non-small cell lung cancer cells (Retraction of Vol 9, Pg 21139, 2019)
Fisher, Laura
RSC ADVANCES, 2021, 11 (09) : 5265 - 5265
[4] RETRACTED: MiR-148a agomir based targeting of c-Met and Her-3 is able to attenuate EGFR-T790M mutation driven gefitinib and erlotinib resistance in non-small cell lung cancer cells (Retracted article. See vol. 11, pg. 5265, 2021)
Chen, Guimin
Ye, Lei
Han, Yufei
Han, Ping
RSC ADVANCES, 2019, 9 (37) : 21139 - 21146